{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:07:43Z","timestamp":1793754463973,"version":"4.6.1"},"reference-count":20,"publisher":"Japan Neurosurgical Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.2176\/nmccrj.cr.2018-0223","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T22:21:40Z","timestamp":1553120500000},"page":"61-64","source":"Crossref","is-referenced-by-count":3,"title":["A Case of Sarcoidosis-lymphoma Syndrome: Importance of Brain Biopsy"],"prefix":"10.2176","volume":"6","author":[{"given":"Tomoyasu","family":"Yamanaka","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Nagoya City University, Nagoya, Aichi, Japan;"},{"name":"Department of Neurosurgery, Nagoya City East Medical Center, Nagoya, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kanai","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya City East Medical Center, Nagoya, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritaka","family":"Aihara","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya City University, Nagoya, Aichi, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya City East Medical Center, Nagoya, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhito","family":"Mase","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya City University, Nagoya, Aichi, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Brincker H: Sarcoid reactions and sarcoidosis in Hodgkin\u2019s disease and other malignant lymphomata. <i>Br J Cancer<\/i> 26: 120\u2013123, 1972","DOI":"10.1038\/bjc.1972.18"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Brincker H: The sarcoidosis-lymphoma syndrome. <i>Br J Cancer<\/i> 54: 467\u2013473, 1986","DOI":"10.1038\/bjc.1986.199"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Greiner EJ, M\u00fcgge LO, Romeike BF, et al.: A case with coincidental diagnosis of primary central nervous system lymphoma and lymph node sarcoidosis. <i>J Neurooncol<\/i> 99: 129\u2013134, 2010","DOI":"10.1007\/s11060-009-0101-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Nowak DA, Widenka DC: Neurosarcoidosis: a review of its intracranial manifestation. <i>J Neurol<\/i> 248: 363\u2013372, 2001","DOI":"10.1007\/s004150170175"},{"key":"5","unstructured":"5) Ginat DT, Dhillon G, Almast J: Magnetic resonance imaging of neurosarcoidosis. <i>J Clin Imaging Sci<\/i> 1: 15, 2011"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Lacomis D: Neurosarcoidosis. <i>Curr Neuropharmacol<\/i> 9: 429\u2013436, 2011","DOI":"10.2174\/157015911796557975"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Lai PH, Hsu SS, Ding SW, et al.: Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions. <i>Surg Neurol<\/i> 68 Suppl 1: S25\u2013S36, 2007","DOI":"10.1016\/j.surneu.2007.07.080"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Toh CH, Wei KC, Chang CN, Ng SH, Wong HF: Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction. <i>AJNR Am J Neuroradiol<\/i> 34: 1145\u20131149, 2013","DOI":"10.3174\/ajnr.A3383"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Xu W, Wang Q, Shao A, Xu B, Zhang J: The performance of MR perfusion-weighted imaging for the differentiation of high-grade glioma from primary central nervous system lymphoma: A systematic review and meta-analysis. <i>PLoS One<\/i> 12: e0173430, 2017","DOI":"10.1371\/journal.pone.0173430"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Cohen PR, Kurzrock R: Sarcoidosis and malignancy. <i>Clin Dermatol<\/i> 25: 326\u2013333, 2007","DOI":"10.1016\/j.clindermatol.2007.03.010"},{"key":"11","unstructured":"11) London J, Grados A, Ferm\u00e9 C, et al.: Sarcoidosis occurring after lymphoma: report of 14 patients and review of the literature. <i>Medicine<\/i> (<i>Baltimore<\/i>) 93: e121, 2014"},{"key":"12","unstructured":"12) Linnenberg HS, Medici TC, Rhyner K: [The \u201csarcoidosis-lymphoma syndrome\u201d\u2014a lymphocyte dysregulation?]. <i>Pneumologie<\/i> 46: 229\u2013235, 1992 (German)"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Coulon A, Lafitte F, Hoang-Xuan K, et al.: Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients. <i>Eur Radiol<\/i> 12: 329\u2013340, 2002","DOI":"10.1007\/s003300101037"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Erdag N, Bhorade RM, Alberico RA, Yousuf N, Patel MR: Primary lymphoma of the central nervous system: typical and atypical CT and MR imaging appearances. <i>AJR Am J Roentgenol<\/i> 176: 1319\u20131326, 2001","DOI":"10.2214\/ajr.176.5.1761319"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Adachi K, Yamaguchi F, Node Y, Kobayashi S, Takagi R, Teramoto A: Neuroimaging of primary central nervous system lymphoma in immunocompetent patients: comparison of recent and previous findings. <i>J Nippon Med Sch<\/i> 80: 174\u2013183, 2013","DOI":"10.1272\/jnms.80.174"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Zhang D, Hu LB, Henning TD, et al.: MRI findings of primary CNS lymphoma in 26 immunocompetent patients. <i>Korean J Radiol<\/i> 11: 269\u2013277, 2010","DOI":"10.3348\/kjr.2010.11.3.269"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Haldorsen IS, Espeland A, Larsson EM: Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. <i>AJNR Am J Neuroradiol<\/i> 32: 984\u2013992, 2011","DOI":"10.3174\/ajnr.A2171"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Sasayama T, Nakamizo S, Nishihara M, et al.: Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL). <i>Neuro-oncology<\/i> 14: 368\u2013380, 2012","DOI":"10.1093\/neuonc\/nor203"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Murakami S: Soluble interleukin-2 receptor in cancer. <i>Front Biosci<\/i> 9: 3085\u20133090, 2004","DOI":"10.2741\/1461"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Aulbert E, Steffens O: [Beta 2 microglobulin in serum\u2014a \u201ctumor marker\u201d in malignant lymphomas?] <i>Med Klin<\/i> (<i>Munich<\/i>) 85: 13\u201317, 1990 (German)","DOI":"10.1159\/000216735"}],"container-title":["NMC Case Report Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/6\/2\/6_cr.2018-0223\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T02:30:35Z","timestamp":1663122635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/6\/2\/6_cr.2018-0223\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2176\/nmccrj.cr.2018-0223","relation":{},"ISSN":["2188-4226"],"issn-type":[{"value":"2188-4226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}